Compounds > imipramine

imipramine and propofol

imipramine has been researched along with propofol in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (72.73)	29.6817
2010's	3 (27.27)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Chang, TK; Ensom, MH; Kiang, TK	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Burchell, B; Riley, RJ; Soars, MG	1
Fujiwara, R; Ikushiro, S; Katoh, M; Nakajima, M; Nakamura, A; Sakaki, T; Yamanaka, H; Yokoi, T	1
Fujiwara, R; Katoh, M; Nakajima, M; Yamanaka, H; Yokoi, T	1
Ando, A; Higashi, E; Iwano, S; Miyamoto, Y; Murayama, N; Yamazaki, H	1

Reviews

3 review(s) available for imipramine and propofol

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacology & therapeutics, 2005, Volume: 106, Issue:1 Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

8 other study(ies) available for imipramine and propofol

Article	Year
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Evaluation of the marmoset as a model species for drug glucuronidation. Xenobiotica; the fate of foreign compounds in biological systems, 2001, Volume: 31, Issue:12 Topics: Animals; Callithrix; Female; Glucuronates; Imipramine; Inactivation, Metabolic; Kidney; Male; Microsomes, Liver; Models, Animal; Morphine; Propofol; Rats; Rats, Sprague-Dawley; Species Specificity	2001
Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:5 Topics: Catalysis; Cell Line; Detergents; Enzyme Stability; Estradiol; Gene Expression Regulation, Enzymologic; Glucuronides; Glucuronosyltransferase; Humans; Imipramine; Immunoblotting; Immunoprecipitation; Isoenzymes; Kinetics; Octoxynol; Propofol; Serotonin; Temperature; Transfection; UDP-Glucuronosyltransferase 1A9	2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:2 Topics: Cell Line; Enzyme Inhibitors; Glucuronides; Glucuronosyltransferase; Humans; Imipramine; Microsomes, Liver; Naphthols; Propofol; Recombinant Proteins; Serotonin; Uridine Diphosphate	2008
Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig. Biopharmaceutics & drug disposition, 2014, Volume: 35, Issue:6 Topics: Adult; Aged; Animals; Chromatography, Liquid; Dogs; Estradiol; Female; Glucuronides; Glucuronosyltransferase; Humans; Imipramine; Macaca fascicularis; Male; Mice, Inbred ICR; Microsomes, Liver; Middle Aged; Morphine; Propofol; Rats, Sprague-Dawley; Serotonin; Species Specificity; Swine; Swine, Miniature; Tandem Mass Spectrometry; Young Adult; Zidovudine	2014